# Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

> **NCT02511522** · NA · COMPLETED · sponsor: **Canadian Cancer Trials Group** · enrollment: 66 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Metastases

## Interventions

- **OTHER:** Best Supportive Care
- **RADIATION:** Palliative Radiation Therapy

## Key facts

- **NCT ID:** NCT02511522
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-11
- **Primary completion:** 2022-10-26
- **Final completion:** 2024-10-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02511522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02511522, "Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02511522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*